GOAL


Expand the brand to elevate the Evofem Biosciences® corporate website, investor presentation and oversee the IR transition within 12 weeks to elevate the investor’s journey to drive interest and action.

SOLUTION


Evofem Biosciences exists to advance the lives of women by putting a woman in control of her sexual and reproductive health. 325 developed a sophisticated corporate brand approach and aligned with the consumer-facing Phexxi® brand. The strategic visual communications deliver the right story and information sought quickly, succinctly to engage and incite within seconds.

DELIVERABLES


BRAND STRATEGY + GUIDELINES
WEBSITE DESIGN + DEVELOPMENT
CONTENT STRATEGY + WRITING
INVESTOR PRESENTATION
PR TEMPLATE
EMAIL TEMPLATE
IR PLATFORM DESIGN + TRANSITION

VIEW WEBSITE

STRATEGY


325 positioned the Evofem Biosciences corporate brand as a powerhouse in women’s healthcare. Elevating the brand to showcase a sophisticated look and feel with the hierarchy of messaging from top to bottom. Utilizing imagery, typography, photography, colors, tone and feel to speak to varied targeted audiences. Whether an investor, a health care provider or a consumer visits the website, it speaks to all audiences as a whole on the initial home page. Audiences are educated immediately as to who Evofem is, the organization’s mission, offerings and brand promise.

INVESTOR RELATIONS


Our team works in tandem with our client’s investor relations partner and integrates the overall brand to the IR portion of the website.

BRAND GUIDELINES


Brand guidelines define rules that show how your brand should be represented. Brand guidelines help ensure consistency and demonstrate what the company is, what it does and what it stands for.

ABOUT EVOFEM


Evofem Biosciences, Inc. is developing and commercializing innovative products and product candidates to address unmet needs in women’s sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (chlamydia and gonorrhea).

ADDITIONAL CASE STUDIES


Click an image below to view more case studies.